STOCK TITAN

TerrAscend to Host Third Quarter 2025 Earnings Conference Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

TerrAscend (OTCQX: TSNDF) will host a conference call to discuss third quarter results for the period ended September 30, 2025 on Thursday, November 6, 2025 at 5:00 p.m. Eastern Time. The company will release its Q3 2025 financial results the same day after market close.

Investors can join the webcast at https://app.webinar.net/6dvVkb2k4bz or dial 1-888-510-2154. A replay is available until midnight Eastern Time on November 20, 2025 at 1-289-819-1450 or 1-888-660-6345 (Replay code: 73897#).

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-4.16% News Effect

On the day this news was published, TSNDF declined 4.16%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that it will host a scheduled conference call to discuss the results for its third quarter ended September 30, 2025 on Thursday, November 6, 2025 at 5:00 p.m. Eastern Time. The Company will report its financial results for the third quarter 2025 the same day after market close.

CONFERENCE CALL DETAILS
  
Date:Thursday, November 6, 2025
Time:5:00 p.m. Eastern Time
Webcast:https://app.webinar.net/6dvVkb2k4bz
Dial-in Number:1-888-510-2154
Replay:



1-289-819-1450 or 1-888-660-6345

Available until 12:00 midnight Eastern Time on Thursday, November 20, 2025
Replay Entry Code: 73897#
  

About TerrAscend
TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. For more information visit www.terrascend.com.

For more information regarding TerrAscend:
Ziad Ghanem
Chief Executive Officer
IR@terrascend.com
689-345-4114
IR@terrascend.com

Investor Relations Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
Valter@KCSA.com 
212-896-1254


FAQ

When will TerrAscend (TSNDF) release Q3 2025 results and hold the earnings call?

TerrAscend will report Q3 2025 results and hold the conference call on Thursday, November 6, 2025; the call starts at 5:00 p.m. ET.

How can I join TerrAscend's November 6, 2025 Q3 call for TSNDF?

Join the live webcast at https://app.webinar.net/6dvVkb2k4bz or dial 1-888-510-2154 to participate.

Will there be a replay of TerrAscend's Q3 2025 earnings call for TSNDF?

Yes. Replay is available until midnight ET on November 20, 2025 at 1-289-819-1450 or 1-888-660-6345 using code 73897#.

What period does TerrAscend's Q3 2025 earnings call cover for TSNDF?

The call discusses results for the third quarter ended September 30, 2025.

Will TerrAscend (TSNDF) publish financial results before the November 6, 2025 call?

TerrAscend will release its Q3 2025 financial results after market close on November 6, 2025, prior to the 5:00 p.m. ET call.

Where can investors find the TerrAscend Q3 2025 webcast recording for TSNDF?

The live webcast link is https://app.webinar.net/6dvVkb2k4bz; the phone replay numbers and code are provided for on-demand listening until November 20, 2025.
Terrascent

OTC:TSNDF

TSNDF Rankings

TSNDF Latest News

TSNDF Latest SEC Filings

TSNDF Stock Data

298.73M
219.57M
6.31%
2.36%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
King of Prussia